Sunil Kumar

Sunil Kumar is an Assistant Professor of Pharmaceutical Sciences at the College of Pharmacy and Health Sciences, St. John's University. He holds a Ph.D. and M.P.H. from St. John's University. His research focuses on diabetes, obesity, and nonalcoholic fatty liver disease (NAFLD), particularly investigating the role of lipocalin-type prostaglandin D2 synthase (L-PGDS) in metabolic pathways. His lab uses mouse models and in vitro systems to study L-PGDS's influence on NAFLD progression and potential therapeutic targets.

Education:

• M.P.H. from St. John's University (2009)
• Ph.D. in Pharmaceutical Sciences from St. John's University (2014)

Research interests include lipid metabolism, PGD2 signaling pathways, and translational therapies for metabolic disorders. His work bridges basic research with clinical applications, collaborating with institutions like NYU Langone and Columbia University.

Key findings include demonstrating that L-PGDS knockout mice develop NAFLD independently of diet, highlighting new therapeutic avenues. Current projects explore DP1/DP2 receptor modulators as NAFLD treatments.

Advising: Supervises graduate students in metabolic disease research. Collaborates on grants investigating NAFLD pathogenesis and pharmacological interventions. His lab focuses on hepatic lipid regulation and drug delivery systems.

Labs/Teams: Leads a research group at St. John's University collaborating with NYU Langone Hospital—Long Island on NAFLD and diabetes research.